Etiology and Pathogenesis in Primary Sclerosing Cholangitis
The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Abstract
The etiology and pathogenesis of the inflammatory and fibrotic bile duct lesions characteristic of primary sclerosing cholangitis (PSC) is unknown, but several lines of evidence support the contention that genetic and immunologic factors are involved. There is an association with human leukocyte antigens (HLA) with an increased frequency of DR3, DR6, and DR2 positive haplotypes. DRB3*0101(DR52a) is the most strongly associated allele in some studies, but the HLA gene conferring the primary HLA associated susceptibility to PSC remains to be established. There is an aberrant expression of HLA class II antigens (DR and DP) on bile duct epithelial cells, with the potential to present antigens to the surrounding T-lymphocytes. A defective suppressor T-cell function has been suggested in some studies. The patients may have elevated levels of circulating immune complexes, immunoglobulins, and non-organ-specific autoantibodies. Antibodies to perinuclear antigens (pANCA) are present in about 80% of cases. Increased metabolism of complement C3, reduced clearance of immune complexes, and increased concentration of biliary immune complexes have been found. The strong association between PSC and ulcerative colitis (UC) has not been explained. The detection of circulating IgG antibodies against a specific epitope shared by epithelial cells in the bile ducts and colon in about two-thirds of PSC patients may be of importance. Portal bacteremia secondary to a diseased bowel may possibly contr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Portal bacteraemia, reported in patients with active colitis, may be another important contributing factor.225,226”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [226]
Citations
Cites
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY
Bottazzo, G., Hanafusa, T., Pujol-Borrell, R., & Feldmann, M. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90629-3 · Cited by 1,256
Ohashi, P. S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C. T., Odermatt, B., Malissen, B., Zinkernagel, R. M., & Hengartner, H. (1991) · Cell · doi:10.1016/0092-8674(91)90164-t · Cited by 1,173
Serum levels of cytokines in chronic liver diseases
Tilg, H., Wilmer, A., Vogel, W., Herold, M., Nölchen, B., Judmaier, G., & Huber, C. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91122-k · Cited by 739
Chapman, R. W., Arborgh, B. A., Rhodes, J. M., Summerfield, J. A., Dick, R., Scheuer, P. J., & Sherlock, S. (1980) · Gut · doi:10.1136/gut.21.10.870 · Cited by 732
Transforming Growth Factors β1 and α in Chronic Liver Disease: Effects of Interferon Alfa Therapy
Castilla, A., Prieto, J., & Fausto, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241401 · Cited by 655
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
Wiesner, R. H., Grambsch, P. M., Dickson, R. E., Ludwig, J., Maccarty, R. L., Hunter, E. B., Fleming, T. R., Fisher, L. D., Beaver, S. J., & Larusso, N. F. (1989) · Hepatology · doi:10.1002/hep.1840100406 · Cited by 643
Fibrogenic cytokines: the role of immune mediators in the development of scar tissue
Kovacs, E. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90107-5 · Cited by 590
Campbell, R. D., & Trowsdale, J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90234-c · Cited by 579
Clinicopathologic features of the syndrome of primary sclerosing cholangitis
Wiesner, R. H., & LaRusso, N. F. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90131-6 · Cited by 550
Saxon, A., Shanahan, F., Landers, C., Ganz, T., & Targan, S. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80067-3 · Cited by 513
Autoimmune Diseases: The Failure of Self Tolerance
Sinha, A. A., Lopez, M. T., & McDevitt, H. O. (1990) · Science · doi:10.1126/science.1972595 · Cited by 493
Ballardini, G., Bianchi, F., Doniach, D., Mirakian, R., Pisi, E., & Bottazzo, G. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91108-5 · Cited by 488
Natural history and prognostic variables in primary sclerosing cholangitis
Farrant, J. M., Hayllar, K. M., Wilkinson, M. L., Karani, J., Portmann, B. C., Westaby, D., & Williams, R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90673-9 · Cited by 468
A new look at the arterial supply of the bile duct in man and its surgical implications
Northover, J. M. A., & Terblanche, J. (1979) · Journal of British Surgery · doi:10.1002/bjs.1800660603 · Cited by 442
Guilt and dynamics of psychological disorder.
BRINKMANN, D., & Rickman, J. (1948) · PubMed · Cited by 417
PHENOTHIAZINE DYSKINESIA AFTER LEUCOTOMY
(1964) · The Lancet · doi:10.1016/s0140-6736(64)90197-7 · Cited by 397
Duerr, R. H., Targan, S. R., Landers, C. J., Larusso, N. F., Lindsay, K. L., Wiesner, R. H., & Shanahan, F. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)70028-v · Cited by 357
Nomenclature for factors of the HLA system, 1991
Bodmer, J. G., Marsh, S. G. E., Albert, E. B., Bodmer, W. F., Oupont, B., Erlich, H. A., Mach, B., Mayr, W. R., Parham, P., Sasazuki, T., et al. (1992) · Tissue Antigens · doi:10.1111/j.1399-0039.1992.tb01932.x · Cited by 337
Primary sclerosing cholangitis: findings on cholangiography and pancreatography.
MacCarty, R. L., LaRusso, N. F., Wiesner, R. H., & Ludwig, J. (1983) · Radiology · doi:10.1148/radiology.149.1.6412283 · Cited by 333
Ludwig, J., Barham, S. S., Larusso, N. F., Elveback, L. R., Wiesner, R. H., & McCall, J. T. (1981) · Hepatology · doi:10.1002/hep.1840010612 · Cited by 328
O'Grady, J., Sutherland, S., Harvey, F., Calne, R., Alexander, G. M., Donaldson, P., Portmann, B., & Williams, R. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92356-2 · Cited by 296
Acquired immunodeficiency syndrome cholangiopathy: Spectrum of disease
Cello, J. P. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90381-1 · Cited by 277
Primary Sclerosing Cholangitis: A Long-Term Follow-up Study
Aadland, E., Schrumpf, E., Fausa, O., Elgjo, K., Heilo, A., Aakhus, T., & Gjone, E. (1987) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528709011139 · Cited by 276
Self-citationAssociation of primary sclerosing cholangitis with HLA-B8.
Chapman, R. W., Varghese, Z., Gaul, R., Patel, G., Kokinon, N., & Sherlock, S. (1983) · Gut · doi:10.1136/gut.24.1.38 · Cited by 260
Orthotopic Liver Transplantation for Primary Sclerosing Cholangitis
MARSH, J. W., IWATSUKI, S., MAKOWKA, L., ESQUIVEL, C. O., GORDON, R. D., TODO, S., TZAKIS, A., MILLER, C., THIEL, D. V., & STARZL, T. E. (1988) · Annals of Surgery · doi:10.1097/00000658-198801000-00005 · Cited by 253
Biliary Atresia and Reovirus Type 3 Infection
Morecki, R., Glaser, J. H., Cho, S., Balistreri, W. F., & Horwitz, M. S. (1982) · New England Journal of Medicine · doi:10.1056/nejm198208193070806 · Cited by 227
Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases
Mulder, A. (1993) · Hepatology · doi:10.1016/0270-9139(93)90052-o · Cited by 212
Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth
Lichtman, S. N., Sartor, R. B., Keku, J., & Schwab, J. H. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90833-m · Cited by 209
Sclerosing Cholangitis in Ulcerative Colitis
Schrumpf, E., Elgjo, K., Fausa, O., Gjone, E., Kolmannskog, F., & Ritland, S. (1980) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528009181516 · Cited by 206
Self-citationIntestinal Endotoxins As Mediators of Hepatic Injury—An Idea Whose Time Has Come Again
Nolan, J. P. (1989) · Hepatology · doi:10.1002/hep.1840100523 · Cited by 205
Schrumpf, E., Fausa, O., Førre, Ø., Dobloug, J. H., Ritland, S., & Thorsby, E. (1982) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528209182038 · Cited by 204
Self-citationPrimary sclerosing cholangitis
Warren, K. W., Athanassiades, S., & Monge, J. I. (1966) · The American Journal of Surgery · doi:10.1016/0002-9610(66)90339-4 · Cited by 198
Seibold, F., Weber, P., Klein, R., Berg, P. A., & Wiedmann, K. H. (1992) · Gut · doi:10.1136/gut.33.5.657 · Cited by 184
Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.
Hohn, D., Melnick, J., Stagg, R., Altman, D., Friedman, M., Ignoffo, R., Ferrell, L., & Lewis, B. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.1.98 · Cited by 176
Das, K. M., Vecchi, M., & Sakamaki, S. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90839-s · Cited by 175
Prospective trial of penicillamine in primary sclerosing cholangitis
LaRusso, N. F., Wiesner, R. H., Ludwig, J., MacCarty, R. L., Beaver, S. J., & Zinsmeister, A. R. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90180-1 · Cited by 172
Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis
Donaldson, P. T., Farrant, M. J., Wilkinson, M. L., Hayllar, K., Portmann, B. C., & Williams, R. (1991) · Hepatology · doi:10.1002/hep.1840130119 · Cited by 169
Association of Primary Sclerosing Cholangitis with HLA-DRw52a
Prochazka, E. J., Terasaki, P. I., Park, M. S., Goldstein, L. I., & Busuttil, R. W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006283222603 · Cited by 168
Mistilis, S. P., & Blackburn, C. R. B. (1970) · The American Journal of Medicine · doi:10.1016/0002-9343(70)90049-5 · Cited by 167
Takahashi, F., & Das, K. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111963 · Cited by 161
Sclerosing Cholangitis after Continuous Hepatic Artery Infusiori of FUDR
KEMENY, M. M., BATTIFORA, H., BLAYNEY, D. W., CECCHI, G., GOLDBERG, D. A., LEONG, L. A., MARGOLIN, K. A., & TERZ, J. J. (1985) · Annals of Surgery · doi:10.1097/00000658-198508000-00007 · Cited by 159
An ischemic basis for biliary strictures.
Terblanche, J., Allison, H. F., & Northover, J. M. A. (1983) · PubMed · Cited by 157
Floxuridine-induced sclerosing cholangitis: An ischemic cholangiopathy?
Ludwig, J., Kim, C. H., Wiesner, R. H., & Krom, R. A. F. (1989) · Hepatology · doi:10.1002/hep.1840090209 · Cited by 156
Primary Sclerosing Cholangitis in Childhood
El-Shabrawi, M. H. F., Wilkinson, M., Portmann, B., Mieli‐Vergani, G., Chong, S. K. F., Williams, R. L., & Mowat, A. P. (1987) · Gastroenterology · doi:10.1016/s0016-5085(87)91082-1 · Cited by 156
Peters, M. G., Vierling, J. M., Gershwin, E. M., Milich, D. R., Chisari, F. V., & Hoofnagle, J. H. (1991) · Hepatology · doi:10.1002/hep.1840130529 · Cited by 156
Halstensen, T. S., Mollnes, T. E., Garred, P., FAUSA, O., & Brandtzæg, P. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90343-y · Cited by 145
Adams, D. H., Hübscher, S. G., Shaw, J., Johnson, G. D., Babbs, C., Rothlein, R., & Neuberger, J. (1991) · Hepatology · doi:10.1002/hep.1840140305 · Cited by 142
Ulcerative Colitis and Persistent Liver Dysfunction
(1983) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067776 · Cited by 138
Farrant, M. J., Doherty, D. G., Donaldson, P. T., Vaughan, R. W., Hayllar, K. M., Welsh, K. I., Eddleston, A. L. W. F., & Williams, R. (1992) · Hepatology · doi:10.1002/hep.1840160217 · Cited by 137
Elevated Circulating Immune Complexes in Primary Sclerosing Cholangitis
Bodenheimer, H. C., LaRusso, N. F., Thayer, W. R., Charland, C., Staples, P. J., & Ludwig, J. (1983) · Hepatology · doi:10.1002/hep.1840030203 · Cited by 136
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.
Chapman, R. W., Cottone, M., Selby, W. S., Shepherd, H. A., Sherlock, S., & Jewell, D. P. (1986) · Gut · doi:10.1136/gut.27.1.86 · Cited by 135
Lobo-Yeo, A., Senaldi, G., Portmann, B. C., Mowat, A. P., Mieli‐Vergani, G., & Vergani, D. (1990) · Hepatology · doi:10.1002/hep.1840120208 · Cited by 133
Primary sclerosing cholangitis in childhood
Ricketts, R. R. (1988) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(88)80783-8 · Cited by 132
HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis
Mehal, W. Z., Lo, Y. M. D., Wordsworth, B. P., Neuberger, J., Hübscher, S. G., Fleming, K. A., & Chapman, R. W. (1994) · Gastroenterology · doi:10.1016/s0016-5085(94)95085-7 · Cited by 131
Familial Occurrence of Primary Sclerosing Cholangitis and Ulcerative Colitis
Quigley, E. M. M., LaRusso, N. F., Ludwig, J., MacSween, R. N. M., Birnie, G. G., & Watkinson, G. (1983) · Gastroenterology · doi:10.1016/s0016-5085(83)80085-7 · Cited by 128
Cangemi, J. R., Wiesner, R. H., Beaver, S. J., Ludwig, J., MacCarty, R. L., Dozois, R. R., Zinsmeister, A. R., & LaRusso, N. F. (1989) · PubMed · Cited by 128
Caustic Sclerosing Cholangitis
Belghiti, J. (1986) · Archives of Surgery · doi:10.1001/archsurg.1986.01400100070014 · Cited by 126
LEUCOCYTE ADHESION TO CELLS IN IMMUNE AND INFLAMMATORY RESPONSES
Patarroyo, M. E., & Makgoba, M. W. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91498-0 · Cited by 122
McFarlane, I. G., Wojcicka, B. M., Tsantoulas, D., Portmann, B. C., Eddleston, A. L. W. F., & Williams, R. L. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90397-4 · Cited by 120
Halstensen, T. S., Das, K. M., & Brandtzaeg, P. (1993) · Gut · doi:10.1136/gut.34.5.650 · Cited by 118
Adams, D. (1991) · Hepatology · doi:10.1016/0270-9139(91)90179-y · Cited by 118
Neopterin in clinical practice
Müller, M. M., Curtius, H., Herold, M., & Huber, C. (1991) · Clinica Chimica Acta · doi:10.1016/0009-8981(91)90019-9 · Cited by 112
Kono, K., Ohnishi, K., Omata, M., Saito, M., Nakayama, T., Hatano, H., Nakajima, Y., Sugita, S., & Okuda, K. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90255-7 · Cited by 111
Snook, J. A., Chapman, R. W., Fleming, K. A., & Jewell, D. P. (1989) · PubMed Central · Cited by 110
Expression of MHC products by normal and abnormal bile duct epithelium
van den Oord, J. J., Sciot, R., & Desmet, V. J. (1986) · Journal of Hepatology · doi:10.1016/s0168-8278(86)80483-4 · Cited by 110
Sclerosing Cholangitis in Ulcerative Colitis: A Follow-up Study
Schrumpf, E., Fausa, O., Kolmannskog, F., Elgjo, K., Ritland, S., & Gjone, E. (1982) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528209181041 · Cited by 109
Self-citationWhiteside, T. L., Lasky, S., Si, L., & Thiel, D. H. V. (1985) · Hepatology · doi:10.1002/hep.1840050321 · Cited by 103
Finegold, M. J., & CARPENTER, R. (1982) · Human Pathology · doi:10.1016/s0046-8177(82)80011-7 · Cited by 97
Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis.
Chapman, R. W., Kelly, P. M., Heryet, A., Jewell, D. P., & Fleming, K. A. (1988) · Gut · doi:10.1136/gut.29.4.422 · Cited by 95
Klein, R., Eisenburg, J., Weber, P., Seibold, F., & Berg, P. A. (1991) · Hepatology · doi:10.1002/hep.1840140632 · Cited by 94
Detection of Circulating Intercellular Adhesion Molecule-1 in Chronic Liver Diseases
Adams, D., Mainolfi, E. A., Burra, P., Neuberger, J., Ayres, R., Elias, E., & Rothlein, R. (1992) · Hepatology · doi:10.1002/hep.1840160330 · Cited by 93
Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium
Mandal, A., Dasgupta, A., Jeffers, L., Squillante, L., Hyder, S., Reddy, R., Schiff, E., & Das, K. M. (1994) · Gastroenterology · doi:10.1016/s0016-5085(94)95271-x · Cited by 92
Spengler, U., Pape, G. R., Hoffmann, R. M., Johnson, J. P., Eisenburg, J., Paumgartner, G., & Riethmüller, G. (1988) · Hepatology · doi:10.1002/hep.1840080304 · Cited by 91
THE LIVER IN ULCERATIVE COLITIS THE SIGNIFICANCE OF RAISED SERUM-ALKALINE-PHOSPHATASE LEVELS
Boden, R. W., Rankin, J. G., Goulston, S. J. M., & Morrow, W. (1959) · The Lancet · doi:10.1016/s0140-6736(59)92049-5 · Cited by 90
Lo, S. K., Fleming, K. A., & Chapman, R. W. (1992) · Gut · doi:10.1136/gut.33.10.1370 · Cited by 83
Hepatobiliary Complications of Inflammatory Bowel Disease
Schrumpf, E., FAUSA, O., Elgjo, K. M., & Kolmannskog, F. (1988) · Seminars in Liver Disease · doi:10.1055/s-2008-1040541 · Cited by 83
Self-citationShea, W. J., Demas, B. E., Goldberg, H. I., Dc, H., Ferrell, L. D., & Kerlan, R. (1986) · American Journal of Roentgenology · doi:10.2214/ajr.146.4.717 · Cited by 79
Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis
Hobson, C. H., Butt, T. J., Ferry, D. M., Hunter, J., CHADWICK, V. S., & Broom, M. F. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90560-4 · Cited by 79
Mieli-Vergani, G., Lobo-Yeo, A., McFarlane, B. M., McFarlane, I. G., Mowat, A. P., & Mieli‐Vergani, G. (1989) · Hepatology · doi:10.1002/hep.1840090206 · Cited by 72
Nouri‐Aria, K. T., Donaldson, P. T., Hegarty, J., Eddleston, A. L. W. F., & Williams, R. L. (1985) · Journal of Hepatology · doi:10.1016/s0168-8278(85)80051-9 · Cited by 71
Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice.
Nagata, M., Yokono, K., Hayakawa, M., Kawase, Y., Hatamori, N., Ogawa, W., Yonezawa, K., Shii, K., & Baba, S. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.4.1155 · Cited by 70
An autoantibody profile in primary sclerosing cholangitis
Zauli, D., Schrumpf, E., Crespi, C., Cassani, F., FAUSA, O., & Aadland, E. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80055-7 · Cited by 69
Self-citationBroomé, U., Glaumann, H., Hultcrantz, R., & Forsum, U. (1990) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529008999209 · Cited by 68
Tumour necrosis factor, cholestatic jaundice, and chronic liver disease.
Jones, A. L., Selby, P. J., Viner, C., Hobbs, S., Gore, M. E., & McElwain, T. J. (1990) · Gut · doi:10.1136/gut.31.8.938 · Cited by 66
Minuk, G. Y., Angus, M. G. N., Brickman, C. M., Lawley, T. J., Frank, M. M., Hoofnagle, J. H., & Jones, E. A. (1985) · Gastroenterology · doi:10.1016/s0016-5085(85)80149-9 · Cited by 63
Lymphocyte subsets in primary sclerosing cholangitis
Lindor, K. D., Wiesner, R. H., Katzmann, J. A., LaRusso, N. F., & Beaver, S. J. (1987) · Digestive Diseases and Sciences · doi:10.1007/bf01296138 · Cited by 62
Ariza, J., Xiol, X., Esteve, M., Bañeres, F. F., Liñares, J., Alonso, T., & Gudiol, F. (1991) · Hepatology · doi:10.1002/hep.1840140115 · Cited by 61
Activation of the complement system in primary sclerosing cholangitis
Senaldi, G., Donaldson, P., Magrin, S., Farrant, J. M., Alexander, G., Vergani, D., & Williams, R. L. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90386-7 · Cited by 60
Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis
Lindor, K. D., Wiesner, R. H., LaRusso, N. F., & Homburger, H. A. (1987) · Hepatology · doi:10.1002/hep.1840070515 · Cited by 59
Boberg, K. M., Schrumpf, E., Fausa, O., Elgjo, K., Kolmannskog, F., Haaland, T., & Holter, E. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409092504 · Cited by 58
Self-citationPRIMARY SCLEROSING CHOLANGITIS OF THE EXTRAHEPATIC BILE DUCTS.
Ib, H., & McKenzie, A. D. (1964) · PubMed · Cited by 58
Zöhrens, G., Armbrust, T., Pirzer, U., zum Büschenfelde, K.-H. M., & Ramadori, G. (1993) · Hepatology · doi:10.1002/hep.1840180408 · Cited by 56
Pol, S., Romana, C., Richard, S., Carnot, F., Dumont, J.-L., Bouche, H., Pialoux, G., Stern, M., Pays, J. F., & Berthelot, P. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91743-n · Cited by 56
Minuk, G. Y., Rascanin, N., Paul, R. W., Lee, P. W. K., Buchan, K., & Kelly, J. K. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80054-5 · Cited by 56
Cangemi, J. R., Wiesner, R. H., Beaver, S. J., Ludwig, J., MacCarty, R. L., Dozois, R. R., Zinsmeister, A. R., & LaRusso, N. F. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90903-7 · Cited by 56
A Study of Liver Disorder in Ulcerative Colitis
Brooke, Β. N., Dykes, P. W., & Walker, F. (1961) · Postgraduate Medical Journal · doi:10.1136/pgmj.37.427.245 · Cited by 55
Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis
Snook, J. A., Chapman, R. W., Sachdev, G. K., Heryet, A. R., Kelly, P. M., Fleming, K. A., & Jewell, D. P. (1989) · Journal of Hepatology · doi:10.1016/0168-8278(89)90073-1 · Cited by 52
Zetterquist, H., Broomé, U., Einarsson, K., & Olerup, O. (1992) · Gut · doi:10.1136/gut.33.7.942 · Cited by 51
Dowsett, J. F., Miller, R. F., Davidson, R., Vaira, D., Polydorou, A. A., Cairns, S. R., & Weller, I. V. D. (1988) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528809090203 · Cited by 51
Bacterial endotoxins and the liver.
Fox, E. S., Broitman, S. A., & Thomas, P. (1990) · PubMed · Cited by 47
Can hepatocytes serve as ‘activated’ immunomodulating cells in the immune response?
Volpes, R., van den Oord, J. J., & Desmet, V. J. (1992) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80121-7 · Cited by 47
Jeffrey, G. P., Reed, W. D., Carrello, S., & Shilkin, K. B. (1991) · Gut · doi:10.1136/gut.32.4.424 · Cited by 37
Family Incidence of Primary Sclerosing Cholangitis Associated with Immunologic Diseases
Jorge, A., Esley, C., & Ahumada, J. J. (1987) · Endoscopy · doi:10.1055/s-2007-1018254 · Cited by 36
Broomé, U., Hultcrantz, R., & Scheynius, A. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309096058 · Cited by 35
Pathogenesis of Sclerosing Cholangitis: The Role of Nonimmune Factors
Sherlock, S. (1991) · Seminars in Liver Disease · doi:10.1055/s-2008-1040416 · Cited by 33
Mehal, W. Z., Hattersley, A. T., Chapman, R. W., & Fleming, K. A. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90076-2 · Cited by 33
Lc, M., & Mm, K. (1992) · PubMed · Cited by 33
Broomé, U., Scheynius, A., & Hultcrantz, R. W. (1993) · Hepatology · doi:10.1002/hep.1840180212 · Cited by 31
Histological features of sclerosing cholangitis in patients with chronic ulcerative colitis.
Barbatis, C., Grases, P. J., Shepherd, H. A., Chapman, R. W., Trowell, J., Jewell, D. P., & McGee, J. O. (1985) · Journal of Clinical Pathology · doi:10.1136/jcp.38.7.778 · Cited by 31
The in Vivo Metabolism of C3 in Hepatobiliary Disease Associated with Ulcerative Colitis
Brinch, L., Teisberg, P., Schrumpf, E., & Åkesson, I. (1982) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528209182243 · Cited by 28
Self-citationEndoscopic retrograde intrahepatic cholangiography in liver diseases
Ayoola, E. A., Vennes, J. A., Silvis, S. E., Rohrmann, C. A., & Ansel, H. J. (1976) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(76)73732-5 · Cited by 26
Experimental Chronic Portal Vein Bacteremia.
Vinnik, I. E., Kern, F., Struthers, J. E., Hill, R., & Guzak, S. V. (1964) · Experimental Biology and Medicine · doi:10.3181/00379727-115-28899 · Cited by 25
Primary sclerosing cholangitis in the presence of a lupus anticoagulant
Kirby, D. F., Blei, A. T., Rosen, S. T., Vogelzang, R. L., & Neiman, H. L. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90412-2 · Cited by 23
Decreased in vitro Production of Tumor Necrosis Factor in Primary Biliary Cirrhosis Patients
Broomé, U., Eriksson, L. S., Sundin, U., & Sundqvist, K. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209165431 · Cited by 23
Zauli, D., Baffoni, L., Cassani, F., Fusconi, M., Lenzi, M., Ballardini, G., Luigi, M., Bianchi, F. B., & Schrumpf, E. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90213-i · Cited by 22
Self-citationEndotoxemia in liver disease — time for re-appraisal?
Triger, D. R. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90928-5 · Cited by 20
Association of primary sclerosing cholangitis with HLA‐DRw52a?
Grunnet, N., Rasmussen, H. H., Tage‐Jensen, U., & Rasmussen, S. N. (1991) · Tissue Antigens · doi:10.1111/j.1399-0039.1991.tb02026.x · Cited by 20
IMMUNE DISORDERS OF THE LIVER AND BILE DUCT
Vierling, J. M. (1992) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00039-x · Cited by 17
Alberti‐Flor, J. J., de Medina, M., Jeffers, L., Dr, S., & Schiff, E. R. (1986) · PubMed · Cited by 16
Himeno, H., Saibara, T., Onishi, S., Yamamoto, Y., & Enzan, H. (1992) · Hepatology · doi:10.1002/hep.1840160220 · Cited by 16
Serious chemical sclerosing cholangitis associated with hepatic arterial 5FU and MMC chemotherapy.
Fukuzumi, S., Moriya, Y., MAKUUCHI, M., & Terui, S. (1990) · PubMed · Cited by 13
Aria, K. T. N., Lombard, M., & Williams, R. (1991) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1991.tb05786.x · Cited by 11
Magrin, S., Nouri‐Aria, K. T., Donaldson, P. T., Wilkinson, M., Portmann, B. C., Williams, R. L., & Eddleston, A. L. W. F. (1989) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(89)90129-3 · Cited by 11
Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis
Donaldson, P. T., Farrant, M., Wilkinson, M., Hayllar, K. M., & Williams, R. L. (1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)91414-r · Cited by 8
SEROLOGICAL AND MOLECULAR ANALYSIS OF HLA IN ISRAELI PRIMARY SCLEROSING CHOLANGITIS PATIENTS
Amar, A. A., Brautbar, C., Goldin, E., Sherman, L., Bar–Meir, S., Shouval, D., Hansen, J. A., & Smith, A. G. (1992) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.1992.tb00072.x · Cited by 6
Sclerosing Cholangitis and Ulcerative Colitis in a Mother and Her Son
Silber, G. H., Finegold, M. J., Wagner, M. L., & Klish, W. J. (1987) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-198701000-00025 · Cited by 6
Tissue distribution of autoantigen specific for primary sclerosing cholangitis.
Lo, S. K., Chapman, R. W., & Fleming, K. A. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.3.246 · Cited by 5
Suppressor T-cell deficiency in primary sclerosing cholangitis
Kilby, A. E., Krawitt, E. L., Albertini, R. J., Chastenay, B. F., & John, A. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01307511 · Cited by 3
Quigley, E. M. M., Beaver, S. J., Wiesner, R. H., & LaRusso, N. F. (1987) · Cited by 3
Research works printed but not linked: 16
- Holubitsky I B, 1964, Can J Surg, 7, 277
- Wiesner R H, 1989, Hepa-tology, 10, 430
- Quigley E MM, 1987, Gastroenterology, 92, 1585
- Shepherd H A, 1983, Q J Med, 208, 503
- Broomé U, 1993, Hepatology, 18, 298
- Boberg K M, 1993, J Hepatol, 18, S97
- Ayres R CS, 1991, Hepatology, 14, 97A
- Boberg K M, Scand J Gastroenterol
- Alberti-Flor J J, 1986, Am J Gastroenterol, 81, 325
- Snook J A, 1989, Clin Exp Immunol, 76, 30
- Mulder A HL, 1993, Hepatology, 17, 411, 10.1002/hep.1840170310 · doi:10.1002/hep.1840170310 · Paper page
- Vidrich A, 1993, Gastroenterology, 104, A1015
- Miller L C, 1992, Am J Gastroenterol, 87, 465
- Fox E S, 1990, Lab Invest, 63, 733
- Fukuzumi S, 1990, Eur J Surg Oncol, 16, 251
- Terblanche J, 1983, Surgery, 94, 52
Cited by
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Boberg, K. M., Fausa, O., Haaland, T., Holter, E., Mellbye, O. J., Spurkland, A., & Schrumpf, E. (1996) · Hepatology · doi:10.1002/hep.510230612 · Cited by 205
Self-citationIncreased frequency of autoimmune diseases in patients with primary sclerosing cholangitis
Saarinen, S. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02085-2 · Cited by 195
“The etiology of PSC remains unknown but several immunological disturbances frequently seen in these patients strongly suggest that the immune system is involved in the etiopathogenetical mechanism (4).”
BackgroundHLA class II haplotypes in primary sclerosing cholangitis patients from five European populations
Spurkland, A., Saarinen, S., Boberg, K. M., Mitchell, S., Broome, U., Caballeria, L., Ciusani, E., Chapman, R., Ercilla, G., Fausa, O., et al. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.530502.x · Cited by 171
Self-citationShetty, K., Rybicki, L., & Carey, W. D. (1997) · Hepatology · doi:10.1002/hep.510250501 · Cited by 125
Metadata
- Authors
- Boberg, K. M., Lundin, K. E. A., & Schrumpf, E.
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 1994-01
- Volume
- 29
- Issue
- sup204
- Pages
- 47-58
- ISSN
- 0036-5521 (ISSN-L)
- 1502-7708
- OpenAlex
- W1999569800
- Cited by
- 53
- References
- 129
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2022: 1 · 2018: 2 · 2016: 3 · 2015: 1 · 2013: 1
- FWCI
- 0.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Scandinavian Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary sclerosing cholangitis, etiology, pathogenesis, HLA-DR3, immune complexes, ulcerative colitis, viral infection, bile duct fibrosis
- MeSH terms
- Antibody Formation, HLA Antigens, Humans, Immunity, Cellular, Cholangitis, Sclerosing, Autoimmunity, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.